Travere Therapeutics, Inc.
TVTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001438533
In the last 90 days, Travere Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 320 institutions reported holding it in 13F filings for Q2 2026, worth $5.98B in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Travere Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 261
- −10 vs. Q4 2025
- Shares held
- 101.4M
- +5.51M (+5.8%) vs. Q4 2025
- Total value
- $3.01B
- −$651.1M (−17.8%) vs. Q4 2025
- New holders
- 49
- 90 more added
- Sold out
- 59
- 93 more reduced
7 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TVTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 320 | $5.98B |
| Q1 2026 | 261 | $3.01B |
| Q4 2025 | 278 | $3.90B |
| Q3 2025 | 238 | $2.41B |
| Q2 2025 | 213 | $1.49B |
| Q1 2025 | 218 | $1.77B |
| Q4 2024 | 197 | $1.66B |
| Q3 2024 | 178 | $1.16B |
| Q2 2024 | 174 | $723.4M |
| Q1 2024 | 175 | $677.4M |
| Q4 2023 | 165 | $769.6M |
| Q3 2023 | 169 | $737.2M |
| Q2 2023 | 169 | $1.27B |
| Q1 2023 | 175 | $1.89B |
| Q4 2022 | 155 | $1.53B |
| Q3 2022 | 171 | $1.72B |
| Q2 2022 | 171 | $1.68B |
| Q1 2022 | 169 | $1.79B |
| Q4 2021 | 169 | $2.04B |
| Q3 2021 | 148 | $1.48B |
| Q2 2021 | 136 | $900.8M |
| Q1 2021 | 150 | $1.56B |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Travere Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Palo Alto Investors LP | 230,453 | $6.85M | 1.05% | +119,734+108.1% | Added |
| Russell Investments Group, Ltd. | 234,265 | $6.96M | 0.01% | −51,046−17.9% | Reduced |
| Universal- Beteiligungs- und Servicegesellschaft mbH | 246,648 | $7.33M | 0.01% | +44,426+22.0% | Added |
| Barclays PLC | 248,861 | $7.39M | 0.00% | −120,669−32.7% | Reduced |
| Engineers Gate Manager LP | 254,401 | $7.56M | 0.09% | +117,793+86.2% | Added |
| Palisades Investment Partners, LLC | 255,240 | $7.58M | 2.97% | +117,472+85.3% | Added |
| First Trust Advisors LP | 268,549 | $7.98M | 0.01% | −73,175−21.4% | Reduced |
| JPMorgan Chase & Co | 288,551 | $7.98M | 0.00% | −33,064−10.3% | Reduced |
| New York State Common Retirement Fund | 293,357 | $8.72M | 0.01% | +43,800+17.6% | Added |
| Affinity Asset Advisors, LLC | 300,000 | $8.91M | 0.52% | 00.0% | Unchanged |
| Loomis Sayles & Co L P | 301,466 | $8.96M | 0.01% | +62,542+26.2% | Added |
| Morgan Stanley | 301,655 | $8.96M | 0.00% | −1,114,242−78.7% | Reduced |
| Jane Street Group, LLC | 302,280 | $8.98M | 0.01% | −89,993−22.9% | Reduced |
| Woodline Partners LP | 302,666 | $8.99M | 0.03% | +138,402+84.3% | Added |
| AQR Capital Management LLC | 305,412 | $9.07M | 0.00% | −47,305−13.4% | Reduced |
| Jacobs Levy Equity Management, Inc | 369,193 | $11.0M | 0.05% | +100,267+37.3% | Added |
| Candriam Luxembourg S.C.A. | 369,995 | $11.0M | 0.06% | −98,561−21.0% | Reduced |
| HSBC Holdings PLC | 396,853 | $11.8M | 0.01% | +396,853 | New |
| Price T Rowe Associates Inc | 404,805 | $12.0M | 0.00% | +9,961+2.5% | Added |
| Legal & General Group Plc | 451,056 | $13.4M | 0.00% | −85,869−16.0% | Reduced |
| Pictet Asset Management Holding SA | 529,757 | $14.7M | 0.02% | −4,857−0.9% | Reduced |
| T. Rowe Price Investment Management, Inc. | 520,604 | $15.5M | 0.01% | +520,604 | New |
| Invesco Ltd. | 523,711 | $15.6M | 0.00% | +49,636+10.5% | Added |
| Eversept Partners, LP | 542,610 | $16.1M | 1.06% | −632,358−53.8% | Reduced |
| Soleus Capital Management, L.P. | 546,000 | $16.2M | 0.66% | +546,000 | New |
| Standard Life Aberdeen plc | 557,147 | $16.6M | 0.03% | +38,790+7.5% | Added |
| Panagora Asset Management Inc | 592,912 | $17.6M | 0.07% | +5,558+0.9% | Added |
| Vanguard Fiduciary Trust Co | 612,622 | $18.2M | 0.00% | +612,622 | New |
| Qube Research & Technologies Ltd | 669,159 | $19.9M | 0.03% | +262,938+64.7% | Added |
| Ensign Peak Advisors, Inc | 715,707 | $21.3M | 0.04% | −89,508−11.1% | Reduced |
| Ra Capital Management, L.P. | 746,841 | $22.2M | 0.24% | +746,841 | New |
| Northern Trust Corp | 781,418 | $23.2M | 0.00% | +19,945+2.6% | Added |
| Charles Schwab Investment Management Inc | 790,812 | $23.5M | 0.00% | −17,377−2.2% | Reduced |
| D. E. Shaw & Co., Inc. | 836,544 | $24.9M | 0.02% | −258,012−23.6% | Reduced |
| UBS Group AG | 856,757 | $25.5M | 0.00% | +434,138+102.7% | Added |
| Fiera Capital Corp | 900,868 | $26.8M | 0.09% | +26,815+3.1% | Added |
| Deutsche Bank AG | 925,919 | $27.5M | 0.01% | +44,239+5.0% | Added |
| Nuveen, LLC | 938,569 | $27.9M | 0.01% | −55,044−5.5% | Reduced |
| Emerald Mutual Fund Advisers Trust | 945,033 | $28.1M | 1.36% | −3,426−0.4% | Reduced |
| Adage Capital Partners GP, L.L.C. | 977,000 | $29.0M | 0.04% | −1,950,000−66.6% | Reduced |
| Wellington Management Group LLP | 1,022,272 | $30.4M | 0.01% | +223,288+27.9% | Added |
| MPM Oncology Impact Management LP | 1,133,365 | $33.7M | 2.60% | +1,133,365 | New |
| Driehaus Capital Management LLC | 1,282,518 | $38.1M | 0.28% | +381,114+42.3% | Added |
| Bank of America Corp | 1,345,111 | $40.0M | 0.00% | −505,244−27.3% | Reduced |
| Rock Springs Capital Management LP | 1,477,954 | $43.9M | 2.59% | −732,368−33.1% | Reduced |
| Two Sigma Investments, LP | 1,508,259 | $44.8M | 0.04% | +351,452+30.4% | Added |
| Emerald Advisers, LLC | 1,557,196 | $46.3M | 1.46% | −36,988−2.3% | Reduced |
| Kynam Capital Management, LP | 1,569,018 | $46.6M | 2.96% | +1,051,134+203.0% | Added |
| Vanguard Portfolio Management LLC | 1,709,139 | $50.8M | 0.00% | +1,709,139 | New |
| Goldman Sachs Group Inc | 1,719,721 | $51.1M | 0.01% | −148,491−7.9% | Reduced |
| Stephens Investment Management Group LLC | 1,798,466 | $53.4M | 0.73% | +76,843+4.5% | Added |
| Renaissance Technologies LLC | 1,966,779 | $58.4M | 0.09% | −280,000−12.5% | Reduced |
| Geode Capital Management, LLC | 2,369,559 | $70.4M | 0.00% | +226,064+10.5% | Added |
| Nomura Asset Management International Inc. | 3,270,513 | $97.2M | 0.17% | −503,051−13.3% | Reduced |
| Vanguard Capital Management LLC | 4,045,812 | $120.2M | 0.00% | +4,045,812 | New |
| Perceptive Advisors LLC | 4,142,551 | $123.1M | 2.43% | −135,629−3.2% | Reduced |
| Armistice Capital, LLC | 4,897,417 | $145.5M | 4.80% | +1,133,526+30.1% | Added |
| State Street Corp | 4,959,988 | $147.4M | 0.01% | +203,322+4.3% | Added |
| BlackRock, Inc. | 7,792,033 | $231.5M | 0.00% | −77,319−1.0% | Reduced |
| FMR LLC | 10,967,967 | $325.9M | 0.02% | +1,350,104+14.0% | Added |
| Janus Henderson Group PLC | 11,419,586 | $339.2M | 0.16% | +908,420+8.6% | Added |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −725,500−100.0% | Sold out |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −700,000−100.0% | Sold out |
| Arrowstreet Capital, Limited Partnership | 0 | $0 | 0.00% | −268,045−100.0% | Sold out |
| Jennison Associates LLC | 0 | $0 | 0.00% | −256,335−100.0% | Sold out |
| Frazier Life Sciences Management, L.P. | 0 | $0 | 0.00% | −241,592−100.0% | Sold out |
| Apis Capital Advisors, LLC | 0 | $0 | 0.00% | −186,002−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −173,383−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −136,065−100.0% | Sold out |
| Lord, Abbett & Co. LLC | 0 | $0 | 0.00% | −135,822−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −109,404−100.0% | Sold out |
| Exome Asset Management LLC | 0 | $0 | 0.00% | −89,052−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −86,297−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −79,747−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −56,010−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −55,366−100.0% | Sold out |
| O'Neil Global Advisors, Inc. | 0 | $0 | 0.00% | −51,191−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −46,632−100.0% | Sold out |
| RFG Advisory, LLC | 0 | $0 | 0.00% | −42,727−100.0% | Sold out |
| Hussman Strategic Advisors, Inc. | 0 | $0 | 0.00% | −31,500−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −29,067−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −27,241−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −20,599−100.0% | Sold out |
| PSP Research LLC | 0 | $0 | 0.00% | −15,272−100.0% | Sold out |
| Baader Bank INC | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| Concurrent Investment Advisors, LLC | 0 | $0 | 0.00% | −11,467−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −11,183−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −9,984−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −8,023−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −8,986−100.0% | Sold out |
| Mark Sheptoff Financial Planning, LLC | 0 | $0 | 0.00% | −7,750−100.0% | Sold out |
| Toroso Investments, LLC | 0 | $0 | 0.00% | −6,891−100.0% | Sold out |
| VARCOV Co. | 0 | $0 | 0.00% | −6,814−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −6,799−100.0% | Sold out |
| denkapparat Operations GmbH | 0 | $0 | 0.00% | −6,634−100.0% | Sold out |
| Quantedge Capital Pte Ltd | 0 | $0 | 0.00% | −6,600−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −6,461−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −6,351−100.0% | Sold out |
| Fiduciary Trust Co | 0 | $0 | 0.00% | −6,083−100.0% | Sold out |
| Wealth Enhancement Advisory Services, LLC | 0 | $0 | 0.00% | −6,261−100.0% | Sold out |